129 related articles for article (PubMed ID: 10764155)
1. Prognostic factors in infants with acute myeloid leukemia.
Pui CH; Raimondi SC; Srivastava DK; Tong X; Behm FG; Razzouk B; Rubnitz JE; Sandlund JT; Evans WE; Ribeiro R
Leukemia; 2000 Apr; 14(4):684-7. PubMed ID: 10764155
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities of chromosome band 11q23 and the MLL gene in pediatric myelomonocytic and monoblastic leukemias. Identification of the t(9;11) as an indicator of long survival.
Martinez-Climent JA; Espinosa R; Thirman MJ; Le Beau MM; Rowley JD
J Pediatr Hematol Oncol; 1995 Nov; 17(4):277-83. PubMed ID: 7583381
[TBL] [Abstract][Full Text] [Related]
3. The prognostic value of MLL-AF9 detection in patients with t(9;11)(p22;q23)-positive acute myeloid leukemia.
Scholl C; Schlenk RF; Eiwen K; Döhner H; Fröhling S; Döhner K;
Haematologica; 2005 Dec; 90(12):1626-34. PubMed ID: 16330435
[TBL] [Abstract][Full Text] [Related]
4. Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometry.
Baer MR; Stewart CC; Lawrence D; Arthur DC; Mrózek K; Strout MP; Davey FR; Schiffer CA; Bloomfield CD
Leukemia; 1998 Mar; 12(3):317-25. PubMed ID: 9529125
[TBL] [Abstract][Full Text] [Related]
5. Adult patients with de novo acute myeloid leukemia and t(9; 11)(p22; q23) have a superior outcome to patients with other translocations involving band 11q23: a cancer and leukemia group B study.
Mrózek K; Heinonen K; Lawrence D; Carroll AJ; Koduru PR; Rao KW; Strout MP; Hutchison RE; Moore JO; Mayer RJ; Schiffer CA; Bloomfield CD
Blood; 1997 Dec; 90(11):4532-8. PubMed ID: 9373264
[TBL] [Abstract][Full Text] [Related]
6. Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.
Pui CH; Chessells JM; Camitta B; Baruchel A; Biondi A; Boyett JM; Carroll A; Eden OB; Evans WE; Gadner H; Harbott J; Harms DO; Harrison CJ; Harrison PL; Heerema N; Janka-Schaub G; Kamps W; Masera G; Pullen J; Raimondi SC; Richards S; Riehm H; Sallan S; Sather H; Shuster J; Silverman LB; Valsecchi MG; Vilmer E; Zhou Y; Gaynon PS; Schrappe M
Leukemia; 2003 Apr; 17(4):700-6. PubMed ID: 12682627
[TBL] [Abstract][Full Text] [Related]
7. Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.
Sorensen PH; Chen CS; Smith FO; Arthur DC; Domer PH; Bernstein ID; Korsmeyer SJ; Hammond GD; Kersey JH
J Clin Invest; 1994 Jan; 93(1):429-37. PubMed ID: 8282816
[TBL] [Abstract][Full Text] [Related]
8. Deregulated expression of EVI1 defines a poor prognostic subset of MLL-rearranged acute myeloid leukemias: a study of the German-Austrian Acute Myeloid Leukemia Study Group and the Dutch-Belgian-Swiss HOVON/SAKK Cooperative Group.
Gröschel S; Schlenk RF; Engelmann J; Rockova V; Teleanu V; Kühn MW; Eiwen K; Erpelinck C; Havermans M; Lübbert M; Germing U; Schmidt-Wolf IG; Beverloo HB; Schuurhuis GJ; Ossenkoppele GJ; Schlegelberger B; Verdonck LF; Vellenga E; Verhoef G; Vandenberghe P; Pabst T; Bargetzi M; Krauter J; Ganser A; Valk PJ; Löwenberg B; Döhner K; Döhner H; Delwel R
J Clin Oncol; 2013 Jan; 31(1):95-103. PubMed ID: 23008312
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in children and adolescents with acute myeloid leukemia (excluding children with Down syndrome and acute promyelocytic leukemia): univariate and recursive partitioning analysis of patients treated on Pediatric Oncology Group (POG) Study 8821.
Chang M; Raimondi SC; Ravindranath Y; Carroll AJ; Camitta B; Gresik MV; Steuber CP; Weinstein H
Leukemia; 2000 Jul; 14(7):1201-7. PubMed ID: 10914543
[TBL] [Abstract][Full Text] [Related]
10. Favorable impact of the t(9;11) in childhood acute myeloid leukemia.
Rubnitz JE; Raimondi SC; Tong X; Srivastava DK; Razzouk BI; Shurtleff SA; Downing JR; Pui CH; Ribeiro RC; Behm FG
J Clin Oncol; 2002 May; 20(9):2302-9. PubMed ID: 11981001
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of minimal residual disease monitoring in acute myeloid leukemia patients with t(9;11)(p22;q23).
Tobal K
Haematologica; 2005 Dec; 90(12):1586A. PubMed ID: 16330423
[No Abstract] [Full Text] [Related]
12. The human homologue of rat NG2, a chondroitin sulfate proteoglycan, is not expressed on the cell surface of normal hematopoietic cells but is expressed by acute myeloid leukemia blasts from poor-prognosis patients with abnormalities of chromosome band 11q23.
Smith FO; Rauch C; Williams DE; March CJ; Arthur D; Hilden J; Lampkin BC; Buckley JD; Buckley CV; Woods WG; Dinndorf PA; Sorensen P; Kersey J; Hammond D; Bernstein ID
Blood; 1996 Feb; 87(3):1123-33. PubMed ID: 8562938
[TBL] [Abstract][Full Text] [Related]
13. Clinical and biological characteristics of adult de novo and secondary acute myeloid leukemia with balanced 11q23 chromosomal anomaly or MLL gene rearrangement compared to cases with unbalanced 11q23 anomaly: confirmation of the existence of different entities with 11q23 breakpoint.
Archimbaud E; Charrin C; Magaud JP; Campos L; Thomas X; Fière D; Rimokh R
Leukemia; 1998 Jan; 12(1):25-33. PubMed ID: 9436917
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and experimental studies of childhood acute myeloid leukemia with 11q23/MLL rearrangements].
He YX; Xue YQ; Wang HY; Shao XJ; Pan JL; Xu J; Yang NC; Ji ZH; Huang YP; Hu SY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2012 Dec; 29(6):677-82. PubMed ID: 23225048
[TBL] [Abstract][Full Text] [Related]
15. Clinical and biological implications of partial tandem duplication of the MLL gene in acute myeloid leukemia without chromosomal abnormalities at 11q23.
Shiah HS; Kuo YY; Tang JL; Huang SY; Yao M; Tsay W; Chen YC; Wang CH; Shen MC; Lin DT; Lin KH; Tien HF
Leukemia; 2002 Feb; 16(2):196-202. PubMed ID: 11840285
[TBL] [Abstract][Full Text] [Related]
16. Chromosome abnormalities and MLL rearrangements in acute myeloid leukemia of infants.
Satake N; Maseki N; Nishiyama M; Kobayashi H; Sakurai M; Inaba H; Katano N; Horikoshi Y; Eguchi H; Miyake M; Seto M; Kaneko Y
Leukemia; 1999 Jul; 13(7):1013-7. PubMed ID: 10400416
[TBL] [Abstract][Full Text] [Related]
17. High IGSF4 expression in pediatric M5 acute myeloid leukemia with t(9;11)(p22;q23).
Kuipers JE; Coenen EA; Balgobind BV; Stary J; Baruchel A; de Haas V; de Bont ES; Reinhardt D; Kaspers GJ; Cloos J; Danen-van Oorschot AA; den Boer ML; Marschalek R; Meyer C; Pieters R; Zwaan CM; van den Heuvel-Eibrink MM
Blood; 2011 Jan; 117(3):928-35. PubMed ID: 21045196
[TBL] [Abstract][Full Text] [Related]
18. The MLL (11q23) and AF-4 (4q21) genes disrupted in t(4;11) acute leukemia: molecular and clinical studies.
Hilden JM; Kersey JH
Leuk Lymphoma; 1994 Jul; 14(3-4):189-95. PubMed ID: 7950907
[TBL] [Abstract][Full Text] [Related]
19. Cytogenetic abnormalities and monosomal karyotypes in children and adolescents with acute myeloid leukemia: correlations with clinical characteristics and outcome.
Manola KN; Panitsas F; Polychronopoulou S; Daraki A; Karakosta M; Stavropoulou C; Avgerinou G; Hatzipantelis E; Pantelias G; Sambani C; Pagoni M
Cancer Genet; 2013 Mar; 206(3):63-72. PubMed ID: 23411131
[TBL] [Abstract][Full Text] [Related]
20. Detailed analysis of FLT3 expression levels in acute myeloid leukemia.
Kuchenbauer F; Kern W; Schoch C; Kohlmann A; Hiddemann W; Haferlach T; Schnittger S
Haematologica; 2005 Dec; 90(12):1617-25. PubMed ID: 16330434
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
